FDA acts against five medical practitioners

Nashik: The Food and Drugs’ Administration (FDA), Nashik division, has started taking action against unauthorized medical practitioners, who are carrying and prescribing allopathic medicine to the patients coming to them without having the requisite knowledge.
Last month, five such medical practitioners were identified in the district. While three are from Nandgaon taluka, one is from Nashik taluka and another is from Satpur area in Nashik city.

Joint director of FDA (drugs), Nashik, Madhuri Pawar said, “The report about the concerned medical practitioners has been sent to the district-level committee which will decide the future course of action.”

“These medical practitioners are unqualified but provide allopathy treatment to patients coming to them. Such people stock large quantities of allopathy medicines and treat patients, including giving injections. This is like playing with the lives of the patients. Hence, action was taken after receiving secret information from a civilian,” said Pawar.

Among these doctors, one had done a correspondence diploma course in herbal medicine and others had a diploma in electropathy alternative medicine and naturopathy. None of them had. the requisite qualifications of treating patients with allopathy medicines.

Pawar said the drugs department had also conducted a special drive in December under the Drugs and Magic Remedies (Objectionable Advertisement) Act, 1954, in which raids were conducted at three places and medicine worth over Rs 12 lakh was seized.

  • Related Posts

    Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

    Andelyn bio sciences Inc, a leading patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has partnered with Queen’s University to develop and manufacture AAV9-GM2, a gene therapy…

    Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

    Cellution Biologics Inc, a biologics company focused on developing, manufacturing and commercializing advanced human tissue-based products, announced the completion of its acquisition of the SimpliDerm hydrated human acellular dermal matrix…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

    Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

    Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

    Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

    ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000

    ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000

    US appeals court sides with Sun Pharma in Lipitor antitrust case

    US appeals court sides with Sun Pharma in Lipitor antitrust case

    Counterfeit Cosmetics Are No Longer a Fringe Problem: 4 in 10 Consumers Report Fake Products, Regulatory Silence Raises Serious Questions

    Counterfeit Cosmetics Are No Longer a Fringe Problem: 4 in 10 Consumers Report Fake Products, Regulatory Silence Raises Serious Questions

    Three arrested for illegal sale of mephentermine sulphate injections in Hyderabad

    Three arrested for illegal sale of mephentermine sulphate injections in Hyderabad